Abstract
Several new nucleosides with an oxetanosyl-N-glycoside group, named oxetanocins, were evaluated for their antiviral activities against varicella-zoster virus (VZV) in human embryo lung cells. 9-(2-deoxy-2-hydroxy-methyl-beta-D-erythro-oxetanosyl)guanine (OXT-G) and 9-(2-deoxy-2-hydroxymethyl-beta-D-erythro-oxetanosyl)-2- aminoadenine were effective against not only thymidine kinase-positive (TK+) VZV (YS strain) but also thymidine kinase-negative (TK-) VZV (YSR strain), whereas carbocyclic OXT-G was effective against TK+ VZV but not against TK- VZV. [3H]OXT-G was incorporated into TK+ VZV-infected cells and TK- VZV-infected cells more than into mock-infected cells and was converted into the triphosphate form.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Davison A. J., Scott J. E. The complete DNA sequence of varicella-zoster virus. J Gen Virol. 1986 Sep;67(Pt 9):1759–1816. doi: 10.1099/0022-1317-67-9-1759. [DOI] [PubMed] [Google Scholar]
- Lacey S. F., Suzutani T., Powell K. L., Purifoy D. J., Honess R. W. Analysis of mutations in the thymidine kinase genes of drug-resistant varicella-zoster virus populations using the polymerase chain reaction. J Gen Virol. 1991 Mar;72(Pt 3):623–630. doi: 10.1099/0022-1317-72-3-623. [DOI] [PubMed] [Google Scholar]
- Nishiyama Y., Yamamoto N., Takahash K., Shimada N. Selective inhibition of human cytomegalovirus replication by a novel nucleoside, oxetanocin G. Antimicrob Agents Chemother. 1988 Jul;32(7):1053–1056. doi: 10.1128/aac.32.7.1053. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nishiyama Y., Yamamoto N., Yamada Y., Daikoku T., Ichikawa Y., Takahashi K. Anti-herpesvirus activity of carbocyclic oxetanocin G in vitro. J Antibiot (Tokyo) 1989 Dec;42(12):1854–1859. doi: 10.7164/antibiotics.42.1854. [DOI] [PubMed] [Google Scholar]
- Nishiyama Y., Yamamoto N., Yamada Y., Fujioka H., Shimada N., Takahashi K. Efficacy of oxetanocin G against herpes simplex virus type 2 and murine cytomegalovirus infections in mice. J Antibiot (Tokyo) 1989 Aug;42(8):1308–1311. doi: 10.7164/antibiotics.42.1308. [DOI] [PubMed] [Google Scholar]
- Sakuma T. Strains of varicella-zoster virus resistant to 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Antimicrob Agents Chemother. 1984 Jun;25(6):742–746. doi: 10.1128/aac.25.6.742. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shimada N., Hasegawa S., Harada T., Tomisawa T., Fujii A., Takita T. Oxetanocin, a novel nucleoside from bacteria. J Antibiot (Tokyo) 1986 Nov;39(11):1623–1625. doi: 10.7164/antibiotics.39.1623. [DOI] [PubMed] [Google Scholar]
- Shimada N., Hasegawa S., Saito S., Nishikiori T., Fujii A., Takita T. Derivatives of oxetanocin: oxetanocins H, X and G, and 2-aminooxetanocin A. J Antibiot (Tokyo) 1987 Dec;40(12):1788–1790. doi: 10.7164/antibiotics.40.1788. [DOI] [PubMed] [Google Scholar]
- Suzutani T., Machida H., Sakuma T. Efficacies of antiherpesvirus nucleosides against two strains of herpes simplex virus type 1 in Vero and human embryo lung fibroblast cells. Antimicrob Agents Chemother. 1988 Jul;32(7):1046–1052. doi: 10.1128/aac.32.7.1046. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Votruba I., Bernaerts R., Sakuma T., De Clercq E., Merta A., Rosenberg I., Holý A. Intracellular phosphorylation of broad-spectrum anti-DNA virus agent (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine and inhibition of viral DNA synthesis. Mol Pharmacol. 1987 Oct;32(4):524–529. [PubMed] [Google Scholar]